1-20 of 1884
Clinical Trials and Observations
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase 2 trial of ibrutinib and nivolumab in patients with relapsed CNS lymphomas

Clinical Trials & Observations
Dai Chihara, Raphael E. Steiner, Ranjit Nair, Lei Feng, Sairah Ahmed, Paolo Strati, Luis Malpica, Donna P. Griffith, Shivon A. Mathew, Wirt Montinez, Gita Masand, Felipe Samaniego, Maria A. Rodriguez, Fredrick B. Hagemeister, Luis E. Fayad, Swaminathan P. Iyer, Loretta J. Nastoupil, Sattva S. Neelapu, Christopher R. Flowers, Jason R. Westin
Journal: Blood Advances
Blood Adv (2025) 9 (7): 1485–1491.
https://doi.org/10.1182/bloodadvances.2024014635
Published: 2025
Journal Articles

Changes in gut microbiota predict neutropenia after induction treatment in childhood acute lymphoblastic leukemia

Clinical Trials & Observations
Maria Ebbesen Sørum, Ulrika Boulund, Silvia De Pietri, Sarah Weischendorff, Christian Enevold, Mathias Rathe, Bodil Als-Nielsen, Henrik Hasle, Sünje Pamp, Jakob Stokholm, Klaus Müller
Journal: Blood Advances
Blood Adv (2025) 9 (7): 1508–1521.
https://doi.org/10.1182/bloodadvances.2024013986
Published: 2025
Includes: Supplemental data
Journal Articles

JAK2 p.R564 germ line variants associated with hereditary thrombocythemia and hematologic neoplasms

Clinical Trials & Observations
Brittany L. Stewart, Hetty E. Carraway, Adriana L. Alvarez, Harry Lesmana, John Molina, Zheng Jin Tu, David S. Bosler, Aaron Gerds, Babal Jha, Emilia Calvaresi, Joy Nakitandwe, Abhay Singh
Journal: Blood Advances
Blood Adv (2025) 9 (7): 1534–1543.
https://doi.org/10.1182/bloodadvances.2024013661
Published: 2025
Journal Articles

Trial eligibility, treatment patterns, and outcome for venetoclax-based therapy in AML: a prospective cohort study

Clinical Trials & Observations
Ofir Wolach, Itai Levi, Boaz Nachmias, Sigal Tavor, Irina Amitai, Yishai Ofran, Chezi Ganzel, Tsila Zuckerman, Doaa Okasha, Ilana Hellmann, Tamar Tadmor, Najib Dally, Jonathan Canaani, Galia Stemer, Moshe Grunspan, Adi Jacob Berger, Neta Frankel, Jenia Berelovich, Alexandra Bleterman, Moran Barak, Raanan Cohen, Yakir Moshe
Journal: Blood Advances
Blood Adv (2025) 9 (7): 1544–1554.
https://doi.org/10.1182/bloodadvances.2024014014
Published: 2025
Includes: Supplemental data
Journal Articles

Differential antibody response to EBV proteome following EBVST immunotherapy in EBV-associated lymphomas

Clinical Trials & Observations
Yomani D. Sarathkumara, Nathan W. Van Bibber, Zhiwei Liu, Helen E. Heslop, Rayne H. Rouce, Anna E. Coghill, Cliona M. Rooney, Carla Proietti, Denise L. Doolan
Journal: Blood Advances
Blood Adv (2025) 9 (7): 1658–1669.
https://doi.org/10.1182/bloodadvances.2024014937
Published: 2025
Includes: Supplemental data
Journal Articles

Allogeneic off-the-shelf CAR T-cell therapy for relapsed or refractory B-cell malignancies

Clinical Trials & Observations
Sanam Shahid, Susan E. Prockop, Georgia C. Flynn, Audrey Mauguen, Charlie O. White, Jennifer Bieler, Devin McAvoy, Kinga Hosszu, Maria I. Cancio, Ann A. Jakubowski, Andromachi Scaradavou, Jaap Jan Boelens, Craig S. Sauter, Miguel-Angel Perales, Sergio A. Giralt, Clare Taylor, Jagrutiben Chaudhari, Xiuyan Wang, Isabelle Rivière, Michel Sadelain, Renier J. Brentjens, Nancy A. Kernan, Richard J. O'Reilly, Kevin J. Curran
Journal: Blood Advances
Blood Adv (2025) 9 (7): 1644–1657.
https://doi.org/10.1182/bloodadvances.2024015157
Published: 2025
Includes: Supplemental data
Journal Articles

ALLG APML5: bioavailability and safety of oral arsenic trioxide assessed during consolidation therapy for APL

Clinical Trials & Observations
Harry J. Iland, John Reynolds, Alan V. Boddy, Hayley B. Schultz, Liane Khoo, Shaun Fleming, Steven W. Lane, Nicholas Weber, Robin Gasiorowski, Tasman Armytage, Rosemary Harrup, Anne-Marie Watson, Peter Tan, Robin Filshie, Fiona Kwok, William Stevenson, Sam Yuen, Ashley P. Ng, Leesa Rowley, Paula Marlton, Andrew H. Wei
Journal: Blood Advances
Blood Adv (2025) 9 (6): 1476–1484.
https://doi.org/10.1182/bloodadvances.2024015397
Published: 2025
Includes: Supplemental data
Journal Articles

Elderberry wine and promyelocytic leukemia

Clinical Trials & Observations
Steven D. Gore
Journal: Blood Advances
Blood Adv (2025) 9 (6): 1474–1475.
https://doi.org/10.1182/bloodadvances.2025015905
Published: 2025
Journal Articles

Imetelstat: drugging telomerase in transfusion-dependent low- and intermediate-1–risk MDS

Clinical Trials & Observations
Joseph Cannova, Rafael Madero-Marroquin, Olatoyosi Odenike
Journal: Blood Advances
Blood Adv (2025) 9 (6): 1390–1391.
https://doi.org/10.1182/bloodadvances.2024013929
Published: 2025
Journal Articles

Real World Outcomes for Young Adult Patients Receiving CD19 CAR T-cell Therapy

Clinical Trials & Observations
Hannah Lust, Liora M. Schultz, Soyang Kwon, Gregory W. Roloff, Ibrahim Aldoss, Christina Baggott, Samuel John, Jenna Rossoff, Kevin O. McNerney, Vanessa A. Fabrizio, Julie-An Talano, Amy Moskop, Kevin J. Curran, Christine L. Phillips, Nicole A. Karras, Susanne H.C. Baumeister, Stacy Cooper, Michelle L. Hermiston, Prakash Satwani, Muna Qayed, Sunil Sudhir Raikar, Margaret L. MacMillan, Erin M. Hall, Khanh Nguyen, Ryan D. Cassaday, Noam E. Kopmar, Vamsi K. Kota, John Mathews, Paul J Shaughnessy, Marc S. Schwartz, Abdullah Ladha, George Yaghmour, Muthu Kumaran, Veronika Bachanova, Sean I Tracy, Tamer Othman, Marlise R. Luskin, Evan C. Chen, Anjali S Advani, Nikeshan Jeyakumar, Katharine Miller, Amy Zhang, Bijal D Shah, Lori S. Muffly, Rawan G. Faramand
Journal: Blood Advances
Blood Adv bloodadvances.2024014846.
https://doi.org/10.1182/bloodadvances.2024014846
Published: 2025
Includes: Supplemental data
Journal Articles

Prognostic role of interim PET in patients with follicular lymphoma: a post-hoc study of FOLL12 trial by FIL

Clinical Trials & Observations
Rexhep Durmo, Stephane Chauvie, Federico Fallanca, Fabrizio Bergesio, Antonio Pinto, Ilaria Del Giudice, Marta Coscia, Paolo Corradini, Emanuele Angelucci, Patrizia Tosi, Roberto Freilone, Filippo Ballerini, Alessia Bari, Domenico Pastore, Pier Luigi Luigi Zinzani, Silvia Anna Maria Bolis, Leonardo Flenghi, Arcangelo Liso, Jacopo Olivieri, Luigi Marcheselli, Michele Merli, Annibale Versari, Luca Guerra, Stefano Luminari
Journal: Blood Advances
Blood Adv bloodadvances.2024014790.
https://doi.org/10.1182/bloodadvances.2024014790
Published: 2025
Includes: Supplemental data
Journal Articles

Long-term outcomes of chemoimmunotherapy with obinutuzumab/chlorambucil in chronic lymphocytic leukemia

Clinical Trials & Observations
Valentin Goede, Kirsten Fischer, Sandra Robrecht, Adam Giza, Martin JS Dyer, Michael J. Eckart, Lothar Müller, Lukáš Smolej, Nadine Kutsch, Anna-Maria Fink, Stephan Stilgenbauer, Michael J Hallek
Journal: Blood Advances
Blood Adv bloodadvances.2024014875.
https://doi.org/10.1182/bloodadvances.2024014875
Published: 2025
Includes: Supplemental data
Journal Articles

Safety, efficacy, and treatment satisfaction in adults with ITP who switched to avatrombopag from another TPO-RA

Clinical Trials & Observations
Michael D Tarantino, Kailash Mosalpuria, Scott Kolodny, Jie Jessica Zhang, Michael Vredenburg, Brian D Jamieson
Journal: Blood Advances
Blood Adv bloodadvances.2024015635.
https://doi.org/10.1182/bloodadvances.2024015635
Published: 2025
Includes: Supplemental data
Journal Articles

Validation of the revised 2022 European LeukemiaNet risk stratification in adult patients with acute myeloid leukemia

Clinical Trials & Observations
Leo Ruhnke, Marius Bill, Sven Zukunft, Jan-Niklas Eckardt, Silvia Schäfer, Sebastian Stasik, Maher Hanoun, Thomas Schroeder, Lars Fransecky, Björn Steffen, Stefan W. Krause, Sebastian Scholl, Andreas Hochhaus, Tim Sauer, Sabrina Kraus, Kerstin Schäfer-Eckart, Martin Kaufmann, Edgar Jost, Tim Brümmendorf, Christoph Schliemann, Jan-Henrik Mikesch, Utz Krug, Mathias Hänel, Anke Morgner, Markus Schaich, Andreas Neubauer, Roland Repp, Dirk Niemann, Ruth Seggewiss-Bernhardt, Achim Meinhardt, Johannes Kullmer, Ulrich Kaiser, Wolfgang Blau, Alexander Kiani, Götz Ulrich Grigoleit, Aristoteles Giagounidis, Alexander A. Wurm, Heidi Altmann, Jan Moritz Middeke, Johannes Schetelig, Carsten Müller-Tidow, Friedrich Stölzel, Claudia D. Baldus, Uwe Platzbecker, Hubert Serve, Martin Bornhäuser, Christian Thiede, Christoph Röllig
Journal: Blood Advances
Blood Adv (2025) 9 (6): 1392–1404.
https://doi.org/10.1182/bloodadvances.2024013304
Published: 2025
Includes: Supplemental data
Journal Articles

Characterization of the phenotypic consequences of the Duffy-null genotype

Clinical Trials & Observations
Micah R. Hysong, Megan M. Shuey, Jennifer E. Huffman, Paul Auer, Alexander Reiner, Laura M. Raffield
Journal: Blood Advances
Blood Adv (2025) 9 (6): 1452–1462.
https://doi.org/10.1182/bloodadvances.2024014399
Published: 2025
Includes: Supplemental data
Journal Articles

Complement C5 Inhibition in early onset HELLP Syndrome

Clinical Trials & Observations
Gloria F Gerber, Robert A. Brodsky, Arthur Jason Vaught
Journal: Blood Advances
Blood Adv bloodadvances.2024014746.
https://doi.org/10.1182/bloodadvances.2024014746
Published: 2025
Includes: Supplemental data
Journal Articles

Neurocognitive Gains Among Ugandan Children with Sickle Cell Anemia on Hydroxyurea: 18-month trial interim results

Clinical Trials & Observations
Shubaya Kasule Naggayi, Dennis Kalibbala, Vincent Mboizi, John M Ssenkusu, Zhezhen Jin, Caterina Rosano, Deogratias Munube, Bill Wambaka, Ruth Namazzi, Phillip G Kasirye, Maxencia Kabatabaazi, Grace Nambatya, Susan Murungi, Catherine Nabaggala, Maria Rwiza Nakafeero, Ian R. Troidl, Robert O Opoka, Richard Idro, Paul Bangirana, Nancy S. Green
Journal: Blood Advances
Blood Adv bloodadvances.2024015073.
https://doi.org/10.1182/bloodadvances.2024015073
Published: 2025
Includes: Supplemental data
Journal Articles

Impact of HLA Alloimmunization on Clinical Outcomes of SAA Treated with Immunosuppressive Therapy

Clinical Trials & Observations
Jibran Durrani, Leonard Chen, Ruba N Shalhoub, Valentina Baez, Joshua Glass, Nuri Cha, Xiaoyang Ma, Zhijie Wu, Shouguo Gao, Jennifer Lotter, Olga Julia Rios, Colin O. Wu, Willy Albert Flegel, Neal S. Young, Emma M. Groarke, Bhavisha A. Patel
Journal: Blood Advances
Blood Adv bloodadvances.2024015301.
https://doi.org/10.1182/bloodadvances.2024015301
Published: 2025
Includes: Supplemental data
Journal Articles

Early daratumumab therapy improves renal outcomes in newly diagnosed myeloma patients admitted with kidney injury

Clinical Trials & Observations
E. Bridget Kim, Jack E. Malespini, Matthew Lei, Samuel S. Han, Cole W. Minsky, Andrew R. Branagan, Elizabeth K. O'Donnell, Diana D. Cirstea, Noopur S. Raje, Andrew J. Yee
Journal: Blood Advances
Blood Adv bloodadvances.2025015901.
https://doi.org/10.1182/bloodadvances.2025015901
Published: 2025
Includes: Supplemental data
Journal Articles

The A-HIPI prediction model in advanced-stage Hodgkin lymphoma: identification of risk groups and creation of an online tool

Clinical Trials & Observations
Matthew J. Maurer, Susan K. Parsons, Jenica N. Upshaw, Angie Mae Rodday, Raphael Mwangi, Sára Rossetti, Jonathan W. Friedberg, Andrea Gallamini, Massimo Federico, Eliza Hawkes, David Hodgson, Peter Johnson, Brian K. Link, Eric Mou, Kerry J. Savage, Pier Luigi Zinzani, Andrew M. Evens
Journal: Blood Advances
Blood Adv (2025) 9 (6): 1366–1369.
https://doi.org/10.1182/bloodadvances.2024014689
Published: 2025